New data presented by ISCRM Director Chuck Murry suggests gene-editing may be the key to clearing a major hurdle for researchers hoping to remuscularize injured hearts with stem cell-derived cardiomyocytes Read More
ISCRM investigators use rainbow cell technology to demonstrate that injected heart cells proliferate, a finding that could help researchers enhance the efficacy of cell therapy for heart disease and other conditions. Read More
Nearly 18 million people die each year from heart disease, making it the leading cause of death in the world. In the United States alone, the economic impact of heart disease exceeds $200 billion, a figure that is expected to rise dramatically. Read More
In an exciting breakthrough that may have implications for stem cell-based treatment of heart disease, the lab of Dr. Deok-Ho Kim at the Institute for Stem Cell and Regenerative Medicine (ISCRM) has successfully used silk-based materials to enhance the development of stem-cell derived cardiomyocytes. In a recent study detailed in the Journal of Materials Chemistry, […] Read More